As Pfizer gears up to defend its patents on transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis in court this week, ...
Pfizer Inc.'s agreements dropping two generic-drug makers from a patent case over copies of its blockbuster heart drug Vyndamax left Hikma Pharmaceuticals Plc the last remaining defendant for a bench ...
BridgeBio (BBIO) rose 2.9% after a court filing appeared to indicate a settlement in a generic patent case over Pfizer's (PFE ...
TRENTON, N.J.-The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales ...
Pfizer has reached an agreement with generic manufacturer Dexcel to end a key patent lawsuit over its Vyndamax heart drug, while European regulators recommended three major therapies from Sanofi, ...
The US Food and Drug Administration (FDA) on Friday approved the first generic versions of Pfizer’s blockbuster pain drug Lyrica (pregabalin). The approvals were granted to Alembic Pharmaceuticals, ...
Pfizer Inc. has recently seen how sales of its biggest-selling drug, anti-cholesterol medication Lipitor, started falling when it had to compete with cheaper generic versions. The pharmaceutical giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results